Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates

by Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Published 2015

Long‐term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy

by Visser, Nicole C.M., Sparidaens, Ellen M., van den Brink, Jan‐Willem, Breijer, Maria C., Boss, Erik A., Veersema, Sebastiaan, Siebers, Albert G., Bulten, Johan, Pijnenborg, Johanna M.A., Bekkers, Ruud L.M.
Published 2016